IMRÉ Corp. autoimmune news

IMRE said it has received a complaint, filed with the U.S. District Court for the Northern District of California, which alleges that its Prosorba column infringes a 1992 U.S. patent, "Protein A perfusion and post-perfusion drug infusion," which was assigned to a California corporation, DTER-ENT Inc., in 1993. ...